These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 150323)

  • 41. [Ipratropium bromide in controlled clinical trials. Short communication (II): Time-response measurements of pulmonary function after ipratropium bromide and isoprenaline].
    Strsemann E
    Arzneimittelforschung; 1976; 26(5a):1015-7. PubMed ID: 134724
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bronchoconstriction by nebulized metabisulfite solutions (SO2) and its modification by ipratropium bromide.
    Seale JP; Temple DM; Tennant CM
    Ann Allergy; 1988 Sep; 61(3):209-13. PubMed ID: 2970816
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The influence of ipratropium bromide and sodium cromoglycate on benzalkonium chloride-induced bronchoconstriction in asthma.
    Miszkiel KA; Beasley R; Holgate ST
    Br J Clin Pharmacol; 1988 Sep; 26(3):295-301. PubMed ID: 2972308
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intranasal ipratropium: inhibition of methacholine induced hypersecretion.
    Borum P
    Rhinology; 1978 Dec; 16(4):225-33. PubMed ID: 154164
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relative efficacy of nebulised ipratropium bromide and fenoterol in acute severe asthma.
    Louw SJ; Goldin JG; Isaacs S
    S Afr Med J; 1990 Jan; 77(1):24-6. PubMed ID: 2136775
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Controlled clinical study of the effects of a single aerosol administration of a fenoterol-ipratropium bromide combination in comparison with salbutamol].
    Ginesu F; Ortu AR; Schena GP; Deiola G; Polo F
    Arch Monaldi; 1983; 38(5-6):241-54. PubMed ID: 6238579
    [No Abstract]   [Full Text] [Related]  

  • 47. Influence of albuterol, cromolyn sodium and ipratropium bromide on the airway and circulating mediator responses to allergen bronchial provocation in asthma.
    Howarth PH; Durham SR; Lee TH; Kay AB; Church MK; Holgate ST
    Am Rev Respir Dis; 1985 Nov; 132(5):986-92. PubMed ID: 2932989
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effect of Berotec, Atrovent and Becotide on histamine-induced bronchial spasm in patients with chronic bronchitis].
    Kurgan J
    Pneumonol Pol; 1983 Nov; 51(11):561-8. PubMed ID: 6229720
    [No Abstract]   [Full Text] [Related]  

  • 49. Aerosolized metaproterenol in therapy of severe asthma.
    Bierman CW
    Chest; 1978 Jun; 73(6 Suppl):1011-2. PubMed ID: 354880
    [No Abstract]   [Full Text] [Related]  

  • 50. Protective effect of drugs on bronchoconstriction induced by sulphur dioxide.
    Tan WC; Cripps E; Douglas N; Sudlow MF
    Thorax; 1982 Sep; 37(9):671-5. PubMed ID: 6218648
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dose response of ipratropium assessed by two methods.
    Allen CJ; Campbell AH
    Thorax; 1980 Feb; 35(2):137-9. PubMed ID: 6445607
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical comparison of Atrovent and a placebo in patients with chronic obstructive lung diseases].
    Lien JT
    Tidsskr Nor Laegeforen; 1980 Jul; 100(19-21):1193-5. PubMed ID: 6448492
    [No Abstract]   [Full Text] [Related]  

  • 53. Optimal dose of fenoterol by metered-dose inhaler in asthmatic adults.
    Conrad SA; Light RW; George RB
    Chest; 1986 Mar; 89(3):394-7. PubMed ID: 3512188
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Double inhalation test with ipratropium bromide and salbutamol--assessment of its effects on partial and maximum expiratory flow-volume curves].
    Kamio Y; Shibayama M; Kawai K; Futamata H; Matsubara F; Kanamori K; Uotani K; Okafuji K; Fujimura M; Koshino T
    Rinsho Byori; 1985 Nov; 33(11):1313-8. PubMed ID: 2869163
    [No Abstract]   [Full Text] [Related]  

  • 55. Comparison of the effects of inhaled ipratropium bromide and salbutamol on the bronchoconstrictor response to hypocapnic hyperventilation in normal subjects.
    Jamison JP; Glover PJ; Wallace WF
    Thorax; 1987 Oct; 42(10):809-14. PubMed ID: 2962333
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Long term effect of ipratropium bromide on gastric secretion].
    Dotevall G; Walan A
    Arzneimittelforschung; 1978; 28(11):2163-5. PubMed ID: 159057
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Antagonistic effects of ipratropium bromide on bronchial hypertonia induced with beta-blocking agents].
    Carpentiere G; Marino S; Castello F
    G Clin Med; 1981 Nov; 62(11):801-11. PubMed ID: 6461570
    [No Abstract]   [Full Text] [Related]  

  • 58. Sodium cromoglycate in nocturnal asthma.
    Morgan AD; Connaughton JJ; Catterall JR; Shapiro CM; Douglas NJ; Flenley DC
    Thorax; 1986 Jan; 41(1):39-41. PubMed ID: 3085257
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of ipratropium bromide in bronchial asthma.
    Taskar V; Mirchandani L; Mahashur AA; Sharma RR; Kolhatkar VP
    J Postgrad Med; 1992; 38(3):124-6. PubMed ID: 1303412
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Patterns of response to inhaled bronchodilators in asthmatics.
    Paré PD; Lawson LM; Brooks LA
    Am Rev Respir Dis; 1983 Jun; 127(6):680-5. PubMed ID: 6222679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.